Enhanced with L-Carnitine L-Tartrate to support metabolism and featuring 19 essential amino acids for comprehensive wellness support
The combination of D+Q effectively clears senescent cells and positively impacts age-associated conditions and diseases
The first GLP-1RAs Exenatide synthesized by exendin-4 was approved by the FDA in 2005 (Mariam and Niazi, 2024)
The oral GLP-1 medications have a shorter clinical history, and longer-term real-world data is still being gathered
Nonetheless, the common theme is that GLP-1 RAs tend to push the microbiome in a direction associated with metabolic health (greater abundance of SCFA-producing and mucus-associated bacteria, lower abundance of pro-inflammatory organisms), although substantial changes may require prolonged therapy (56)
Khazaei S , Nair S, Ostermann L, Mizuno H, Mak PY, Carter B, Steffen, Boettcher, Ma L, Garcia M, Cuglievan B, Stevens AM, Michael, Andreeff, Nishida Y